|
|
Sandra M. Swain, MD, is the 2012-2013 President of ASCO. She is the Medical Director of the Washington Cancer Institute at the MedStar Washington Hospital Center; a Professor of Medicine at Georgetown University; and an active member of the National Surgical Adjuvant Breast and Bowel Project (NSABP), serving as both a member of the group's Board of Directors and Vice Chair of its Breast Committee. Her research interests are evaluation of novel therapeutics and targeted therapy for locally advanced, specifically inflammatory breast cancer, and metastatic breast cancer. She also has a strong interest in adjuvant therapy of breast cancer and the effect of chemotherapy on ovarian function in this setting.
|
| |
|
 |
Clement A. Adebamowo, MD, ScD, is an associate professor in the Department of Epidemiology and Preventive Medicine within the School of Medicine & Institute of Human Virology at the University of Maryland, Director of the Office of Strategic Information and Research Institute of Human Virology in Nigeria, and serves on the editorial boards of the Journal of Clinical Oncology and the Annals of Surgical Oncology. He served the Society previously as Chair of the International Affairs Committee. Follow Dr. Adebamowo on Twitter @adebamowo.
|
| |
|
|
Jonathan S. Berek, MD, MMS, is Editor-in-Chief of ASCO Connection. Dr. Berek is the Laurie Kraus Lacob Professor and Director of the Stanford Women’s Cancer Center at the Stanford Cancer Institute, where he specializes in gynecologic oncology. He is also Chair of the Department of Obstetrics and Gynecology at Stanford University School of Medicine. Dr. Berek currently serves on the Scientific Program Committee and Integrated Media and Technology Committee. He previously served on the Cancer Education Committee and Tumor Markers Expert Panel. He has been Editor-in-Chief of ASCO Connection (previously ASCO News & Forum) since 2004.
|
| |
|
| Douglas W. Blayney, MD, a medical oncologist, is the Ann and John Doerr Medical Director of the Stanford Cancer Center and a Professor at Stanford University School of Medicine. He served as 2009-2010 ASCO President and is a member of the Quality Oncology Practice (QOPI®) Steering Group.
|
| | |
 |
Anees B. Chagpar, MD, MSc, MA, MPH, FACS, FRCS(C), a breast surgical oncologist, is Director of the Breast Center—Smilow Cancer Hospital at Yale-New Haven; Assistant Director of the Yale Cancer Center, responsible for Diversity and Health Equity; and Associate Professor, Department of Surgery, Yale School of Medicine. She was part of the inaugural ASCO Leadership Development Program and now serves both on the International Affairs Committee and as ASCO’s representative to the Young Physicians’ Section of the American Medical Association. Her clinical and research interests are dedicated to breast cancer.
|
| |
|
 |
John V. Cox, DO, MBA, FACP, is Editor-in-Chief of the Journal of Oncology Practice. He has been a member of Texas Oncology, P.A. since 1992 and serves on the teaching faculty for the internal medicine training program at Methodist Hospitals of Dallas. Dr. Cox is interested in new models/structures of care delivery.
|
| |
|
| Don S. Dizon, MD, FACP, is the Assistant in Medicine at Harvard Medical School and sees patients in the Gillette Center for Gynecologic Oncology at the Massachusetts General Hospital (MGH) Cancer Center. He is also Director of the Oncology Sexual Health Clinic at the MGH Cancer Center and a blogger for MGH. In addition to his regular column on ASCOconnection.org, he is Deputy Editor at UpToDate and the Editor of ASCO’s Educational Book. Follow Dr. Dizon on Twitter @drdonsdizon.
|
| | |
 | Linda R. Duska, MD, a breast surgical oncologist, is Director of the Breast Center—Smilow Cancer Hospital at Yale-New Haven; Assistant Director of the Yale Cancer Center, responsible for Diversity and Health Equity; and Associate Professor, Department of Surgery, Yale School of Medicine. She was part of the inaugural ASCO Leadership Development Program and now serves both on the International Affairs Committee and as ASCO’s representative to the Young Physicians’ Section of the American Medical Association. Her clinical and research interests are dedicated to breast cancer.
|
| | |
 |
Michael Fisch, MD, MPH, Michael Fisch, MD, MPH, is Chair of the Department of General Oncology at The University of Texas M. D. Anderson Cancer Center. His research interests include symptom management, palliative care, cardiotoxicity, and health care disparities. He has served the Society as Chair of the Integrated Media and Technology Committee. Follow Dr. Fisch on Twitter @fischmd. |
| |
|
 |
L. Michael Glodé, MD,
is a professor in the Division of Medical Oncology, School of Medicine at the University of Colorado Denver. He served the Society as Chair of the Integrated Media and Technology Committee and Chair of the Cancer Education Committee. |
| |
|
|
David L. Graham, MD, is Medical Director for Multispecialty Clinical Research Services at Carle Physicians Group, in Urbana, Illinois. His medical interests include genitourinary and hematologic malignancies as well as neuroendocrine tumors. Dr. Graham is 2012-2013 Chair-Elect of the Society’s Integrated Media and Technology Committee. Follow Dr. Graham on Twitter @davidgrahammd.
|
| | |
 |
Heather M. Hylton, MS, PA-C, is the Lead Physician Assistant in the Department of Medicine at Memorial Sloan-Kettering Cancer Center. She serves on ASCO's Integrated Media and Technology Committee and is President of the Association of Physician Assistants in Oncology. Follow Ms. Hylton on Twitter @hmhyltonpac.
|
| |
|
 |
Abdul-Rahman Jazieh, MD, MPH, is Chair of the Department of Oncology, King Abdulaziz Medical City, as well as Professor at King Saud bin Abdulaziz University for Health Sciences, National Guard Health Affairs, Riyadh, Saudi Arabia. Dr. Jazieh's areas of interest are lung cancer, professional development, and improvement of cancer care delivery. He is a member of ASCO's International Affairs Committee. Follow Dr. Jazieh on Twitter @jaziehoncology.
|
| |
|
 |
Michael P. Link, MD, is the 2011-2012 Immediate Past President of ASCO. He is the Lydia J. Lee Professor in Pediatric Oncology at Stanford University School of Medicine. His research interests include the biology and management of non-Hodgkin lymphoma and Hodgkin disease in children and the treatment of sarcomas of bone and soft tissue. |
| |
|
 |
Robert S. Miller, MD, FACP, is a medical oncologist specializing in breast cancer and medical informatics at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.He currently serves on ASCO's Health Information Technology Work Group, the Integrated Media and Technology Committee, and the editorial boards of the Journal of Oncology Practice and Cancer.Net, where he is Editor-in-Chief. He is a former member of the ASCO Board of Directors. Follow Dr. Miller on Twitter @rsm2800.
|
| |
|
|
Beverly Moy, MD, MPH, is the Clinical Director of the Breast Oncology Program and a medical oncologist at the Massachusetts General Hospital. Her specific research interests include breast cancer clinical trials and racial and ethnic disparities in cancer care. Dr. Moy is 2011-2012 Immediate Past Chair of ASCO’s Advisory Group on Health Disparities and Chair of the Ethics Committee. |
| |
|
| Luke Nordquist, MD, FACP, is a urologic medical oncologist and CEO of the Urology Cancer Center, PC and GU Research Network, LLC, in Omaha, Nebraska. He is also co-founder and CEO of CancerOpinions.com and Host of a weekly radio show " Cancer Opinions with Dr. Luke." Dr. Nordquist graduated from the 2010-2011 class of ASCO's Leadership Development Program and is a member of the Government Relations Committee. Follow Dr. Nordquist on Twitter @DrNordquist. |
| | |
 |
George W. Sledge, Jr., MD, is the Ballve-Lantero Professor of Oncology and Professor of Medicine and Pathology at Indiana University Simon Cancer Center. His research interests include the molecular and tumor biology, growth factors, and anti-angiogenic therapy related to breast cancer. Dr. Sledge served the Society as 2010-2011 ASCO President. |
| |
|
 |
Michael A. Thompson, MD, PhD, is a hematologist/oncologist in Southeast Wisconsin. He is transitioning in June to Medical Director of Cancer Research at Aurora Health Care. He has been involved with the NCI Community Cancer Centers Program (NCCCP) Clinical Trials committees, including the Early Phase Working Group. He is a member of the 2012-2013 ASCO Leadership Development Program and has served on the Integrated Media and Technology Committee (2010-2013). He is active in social media; follow Dr. Thompson on Twitter @mtmdphd. |
| |
|
 |
Jamie H. Von Roenn, MD, is a Professor of Medicine at Northwestern University’s Feinberg School of Medicine, member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, and Medical Director of Northwestern Memorial Hospital’s Home Hospice Program. Her professional interests include breast cancer and palliative care. She has served on the ASCO Board of Directors and as chair of numerous committees, including the ASCO Task Force on Pain and Symptom Management Subcommittee. Dr. Von Roenn currently serves on the Professional Development Committee. |
| |
|
 |
Peter Paul Yu, MD, is ASCO's Incoming (2013-2014) President Elect. He is a medical oncologist and hematologist and Director of Cancer Research at Palo Alto Medical Foundation. Since joining ASCO in 1986, Dr. Yu has served on the Quality of Care Committee, Strategic Planning Committee, Health Information Technology Workgroup (current Chair), Integrated Media and Technology Committee, and Board of Directors, among others. Additionally, Dr. Yu is a member of two cooperative groups, the Cancer and Leukemia Group B (CALGB) and the Gynecologic Oncology Group (GOG). He also serves as Co-Chair of the Commission for the Certification of Health Information Technology (CCHIT) Oncology Workgroup and is a member of the CCHIT Research Workgroup. Follow Dr. Yu on Twitter @YupOnc.
|